Prestige Consumer Healthcare
PBH
$64.65
Share price
-0.51%
Change (1 day)
9.15%
Change (1 year)
Categories
Earnings for Prestige Consumer Healthcare (PBH)
Earnings in 2023 (TTM): -$90.82 M
According to Prestige Consumer Healthcare's latest financial reports the company's current earnings (TTM) are -$90.82 M. In 2022 the company made an earning of $0.26 B an increase over its 2021 earnings that were of $0.24 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Prestige Consumer Healthcare from 2005 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$90.82 M | -134.07% |
| 2022 | $0.26 B | 10.21% |
| 2021 | $0.24 B | 12.88% |
| 2020 | $0.21 B | -657.8% |
| 2019 | -$38.42 M | -143.45% |
| 2018 | $88.41 M | -50.46% |
| 2017 | $0.17 B | 52.98% |
| 2016 | $0.11 B | -31.39% |
| 2015 | $0.17 B | 45.68% |
| 2014 | $0.11 B | 10.59% |
| 2013 | $0.10 B | 38.24% |
| 2012 | $76.34 M | 8.79% |
| 2011 | $70.17 M | 55.18% |
| 2010 | $45.22 M | -123.77% |
| 2009 | -$0.2 B | -446.47% |
| 2008 | $54.91 M | 8.03% |
| 2007 | $50.83 M | -3.71% |
| 2006 | $52.78 M | 42.33% |
| 2005 | $37.08 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -23,622.61% | 🇺🇸 USA |
 Procter & Gamble PG | $20.06 B | -22,197.80% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -10,920.42% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | -3,697.26% | 🇺🇸 USA |
 Abbott Laboratories ABT | $6.66 B | -7,437.67% | 🇺🇸 USA |
 Clorox CLX | $0.36 B | -496.39% | 🇺🇸 USA |
 CVS Health CVS | $12.65 B | -14,038.71% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | -7,681.14% | 🇬🇧 UK |
 Rite Aid
RAD | -$1.4 B | 1,432.37% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | $43.72 M | -148.15% | 🇮🇱 Israel |